Latest Breaking News On - ரமேஷ் அரோரா - Page 1 : comparemela.com

Amritsar, April 27 To overcome the shortage and bring down the price of Remdesivir, Amritsar-based Kwality Pharmaceuticals has approached the Union Government, seeking nod for the sale of this anti-viral drug in the domestic market. Only seven Indian companies have the rights to produce and sell Remdesivir injection locally under agreement with US-based Gilead Sciences. Kwality Pharmaceuticals is among other firms that can only manufacture and export the drug. It has a capacity to produce 50,000 doses a day. The firm has sought temporary exemption from patent laws from the Central Drugs Standard Control Organisation. Ramesh Arora, MD, Kwality Pharmaceuticals, said, “Though the Centre has put curbs on Remdesivir export, norms must be relaxed so that we can sell the drug locally to overcome its shortage. The injection can be made available for just Rs 1,500.”

Ramesh aroraSurinder duggalKwality pharmaceuticalsUnion governmentGilead sciencesPunjab pharmaceutical associationTribune news serviceCentral drugs standard control organisationAmritsar based kwality pharmaceuticalsCentral drugs standard controlPharmaceutical associationரமேஷ் அரோராசுரிண்தேர் டுக்கள்குவாலிட்டி மருந்துகள்தொழிற்சங்கம் அரசுகிலியட் அறிவியல்